Abstract
One of the basic principles of clinical oncology is recognition of the extent of disease at the time of presentation and tailoring of therapy to encompass the full extent of the malignant process. Such a process, when applied to individual patients, must take into account the extent of clinically detectable disease, the problems of spread, and the presumed preexisting clinically occult disease. Only then can adequate therapy be offered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cancer Facts and Figures — 1987. New York: American Cancer Society.
Keller D, Kempson RL, Levine G, McLennon C, 1974. Management of the Patient with Early Endometrial Carcinoma. Cancer 33:1108.
Malkasian GD, 1978. Carcinoma of the Endometrium: Effect of Stage and Grade on Survival. Cancer 41:996.
FIGO, 1985. Annual Report on Gynecologigal Cancer. International Federation of Gynecology and Obstetrics, Vol 19.
Aalders JG, Abeler V, Kolstad P, 1984. Clinical (Stage 3) as compared to subclinical intrapelvic tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients. Gynecol Oncol 17:64.
Chambers SK, Kapp DS, Peschel RE, et al., 1987. Prognostic Factors and Sites of Failure in FIGO Stage I, Grade 3 Endometrial Carcinoma.
Creasman WT, Morrow CP, Bundy BN, et al., 1987. Surgical Pathologic Spread Patterns of Endometrial Carcinoma. A Gynecologic Oncology Group Study. Cancer 60:2035–2041.
FIGO 1973. Annual Report on Gynecological Cancer. International Federation of Gynecology and Obstetrics, Vol 15.
Wharton JT, Mikuta JJ, Mettlin C, 1986. Risk Factors in the Current Management in Carcinoma of the Endometrium. Surg Gynecol Obstet 162:515–520.
Schink JC, Lurain JR, Wallemark CB, Chmiel JS, 1987. Tumor Size in Endometrial Cancer: A Prognostic Factor for Lymph Node Metastasis. Obstet Gynecol 70:216–219.
Hricak, Stern JL, Fisher MR, et al., 1987. Endometrial Carcinoma Staging by MR Imaging. Radiology 162:297–305.
Mettler FA, Christie JH, Garcia JF, et al. 1981. Radionuclide Liver and Bone Scanning in the Evaluation of Patients with Endometrial Carcinoma. Radiology 141:777–780.
Nori D, Hilaris BS, Tome M, et al. 1987. Combined Surgery and Radiation in Endometrial Carcinoma: An Analysis of Prognostic Factors. Int J Radiation Oncology Biol Physics 13:489–497.
Duk JM, Aalders JG, Fleuren GJ, de Bruijn HWA, 1986. CA-125: A useful Marker in Endometrial Carcinoma. Am J Obstet Gynecol 155:1097–1102.
Patsner B, Mann WJ, Cohen H, Loesch M, 1988. Predictive Value of Pre-operative Serum CA-125 Levels in Clinically Localized and Advanced Endometrial Carcinoma. Presented at 19th Annual Meeting, Society of Gynecologic Oncologists, Miami, February, 1988.
Frick HC, Munnell EW, Richart RM, et al., 1973. Carcinoma of the Endometrium. Am J Obstet Gynecol 115:663.
De Palo G, Kenda R, Andreola S, Luciano L. Musumeci R, Rilke F, 1982. Endometrial Carcinoma Stage I. Obstet Gynecol 60:225–231.
Kauppila A, Kojansuu E, Vihko R, 1982. Cytosol estrogen and progestin receptors in endometrial carcinoma patients treated with surgery, radioterapy, and progestin. Cancer 50:2157.
Aalders JG, Abeler V, Kolstad P, 1980. Postoperative external irradiation and prognostic parameters in Stage I endometrial carcinoma. Obstet Gynecol 56:419.
Lotocki RJ, Copeland LJ, DePetrillo AD, Muirhead W, 1983. Stage I endometrial carcinoma: Treatment results in 835 patients. Am J Obstet Gynecol 146:141–145.
Bokham JV, 1981. Two Pathogenetic Types of Endometrial Carcioma. Gynecol Oncol 15:10–17.
Quinn MA, Kneale BJ, and Fortune DW, 1985. Endometrial Carcinoma in Premenopausal Women: A Clinicopathological Study. Gynecol Oncol 20:298–306.
Christopherson WM, Connelly PJ, Alberhasky RC, 1983. Carcinoma of the Endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Cancer 51:1705.
Silverberg SG, Bolin MG, DeGiorgi LS, 1972. Adenocanthoma and mixed adeonoquamous carcinoma of the endometrium: A clinicopathologic study. Cancer 30:1307–1314.
Zaino RJ, Kurman R, Herbold D, et al., 1988. The significance of squamous differentiation in endometrial carcinoma. Presented at 19th Annual Meeting of the Society of Gynecologic Oncologists, Miami, February, 1988.
Hendrikson M, Ross J, Eifel PJ, et al., 1982. Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinoma limited to the endometrium. Gynecol Oncol 13:373.
Christopherson WM, Alberhasky RC, Connelly PJ, 1982. Carcinoma of the endometrium II: Papillary adenocarcinoma: A clinical pathological study of 46 cases. Am J Clin Path 77:534.
Ramirez-Gonzalez CE, Adamsons K, Mangual-Vasquez TY, Wallach RC, 1987. Papillary adenocarcinoma in the endometrium. Obstet Gynecol 70:212–215.
Christopherson WM, Alberhasky RC, Connelly PJ, 1982. Carcinoma of the endometrium: I. A clinicopathological study of clear-cell carcinoma and secretory carcinoma. Cancer 49:1511.
Webb GA, Lagios MD, 1986. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 156:1486–1491.
Melham MF, Tobon H, 1987. Mucinous adenocarcinoma of the endometrium: A clinicopathological review of 18 cases. Int J Gynecol Path 6:347–355.
Anderson WA, Taylor PT, Fechner RE, Pinkerton JV, 1987. Endometrial metaplasia associated with endometrial adenocarcinoma. Am J Obstet Gynecol 157:597–604.
Morrow CP. Prognostic factors in endometrial cancer. Annual Clinical Conference on Cancer, Vol 29. Gynecol. Cancer: Diagnosis and treatment strategies. University of Texas System Cancer Center.
Larson DM, Copeland LJ, Gallagher HS, Gershenson DM, Freedman RS, Wharton JT, Kline RC, 1987. Nature of cervical involvement in endometrial carcinoma. Cancer 59:959–962.
Kinsella TJ, Bloomer WD, Lavin PT, Knapp RC, 1980. Stage II Endometrial Carcinoma: 10 year follow up of combined radiation and surgical treatment. Gynecol Oncol 10:290.
Homesley HD, Boronow RC, Lewis JL, 1977. Stage II endometrial adenocarcinoma: Memorial Hospital for cancer, 1949–1965. Obstet Gynecol 49:604.
Onsrud M, Aalders J, Abeler V, Taylor P, 1982. Endometrial Carcinoma with Cervical involvement (Stage II): Prognostic factors and value of combined radiological-surgical treatment. Gynecol Oncol 13:76.
Bruckman JE, Bloomer WD, Marek A, Ehrmann Rl, Knapp RC, 1980. Stage III adenocarcinoma of endometrium: Two prognostic groups. Gynecol Oncol 9:12.
Boronow RC, 1973. A fresh look corpus cancer management. Obstet Gynecol 42:448–451.
Bigelow B, Vekstein V, Demopoulos RI, 1983. Endometrial carcinoma Stage II: Route and extent of spread to the cervix. Obstet Gynecol 62:363.
Grigsby PW, Kuske RR, Perez CA, et al., 1987. Medically inoperable Stage I adenocarcinoma of the endometrium treated with radiotherapy alone. Int J Radiation Oncol Biol Physics 13:483–488.
Aalders J, Abeler V, Kolstad P, Onsrud M, 1980. Postoperative external irradiation and prognostic parameters in Stage I endometrial carcinoma. Obstete Gynecol 56:419–427.
Piver MS, Yazigi R, Blumenson L, Tsukada Y, 1979. A prospective trial comparing hysterectomy, hysterectomy plus vaginal readium, and uterine radium plus hysterectomy in Stage I endometrial carcinoma. Obstet Gynecol 54:85–89.
Fanning J, Evans MC, Peters AJ, et al., 1987. Adjuvant radiotherapy for Stage I, Grade 2 endometrial adenocarcinoma and adenocanthoma with limited myometrial invasion. Obstet Gynecol 70:920–922.
Quinn MA, Cauchi M, Fortune D, 1985. Endometrial carcinoma: steroid receptors and response to medroxy progesterone acetate. Gynecol Oncol 21:314.
Utaaker E, Iverson OE, Skaarland E, 1987. The distribution and prognostic implications of steroid receptors in endometrial carcinomas. Gynec Oncol 28:89–100.
Mackillop WJ, Pringle JF. Stage III endometrial carcinoma. A review of 90 cases. Cancer 56:2519.
Morrow CP, Townsend DE, 1987. Synopsis of Gynecologic Oncology, 3rd Edition. New York: Wiley.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Wain, G., Morrow, C.P. (1989). Surgical management of endometrial cancer. In: Surwit, E.A., Alberts, D.S. (eds) Endometrial Cancer. Cancer Treatment and Reasearch, vol 49. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0867-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0867-6_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8210-5
Online ISBN: 978-1-4613-0867-6
eBook Packages: Springer Book Archive